Glaucoma Trial, Recruiting NCT07145073 Sponsor: National Taiwan University Hospital Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT07145073
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with glaucoma, with vision test results (Humphrey Visual Field 24-2) showing a mean deviation between -22 dB and -5 dB and a Visual Field Index between 10% and 90%, with reliable test results at screening
  • People whose two consecutive visual field tests at the start of the study show results that are close to each other (difference of less than 2 dB)
  • People whose best corrected vision (with glasses or contact lenses if needed) is at or above a certain level (0.2) in the eye being considered for treatment
  • If both eyes meet the study requirements, one eye will be chosen at random by computer for participation
  • People whose eye pressure is considered stable in the opinion of the study doctor
  • People who are able to follow the study schedule and complete all required visits and tasks
  • People who are able to understand and sign a consent form (if vision makes reading difficult, the form will be read aloud in full)
  • People whose eye scan (OCT imaging) shows measurable changes in specific layers of the retina or optic nerve area

Who may not be able to join:

  • People with a history of herpes infection in the eye
  • People with uncontrolled abnormal eye movement (pathological nystagmus)
  • People with a retinal disease that affects their vision
  • People with cloudiness of the cornea that affects their vision
  • People with a cataract that affects their vision
  • People with inflammation inside the eye (such as uveitis)
  • People who have an implanted electronic device, such as a pacemaker
  • People with a rheumatological or autoimmune disease
  • People with a brain tumour or magnetic metal implants inside the skull
  • People with a history of epilepsy
  • People with skin lesions around the eye area
  • People with significant anxiety, as measured by a score above 12 on the Geriatric Anxiety Scale
  • People with a history of claustrophobia
  • People who have taken part in another clinical trial within the past 3 months that involved medication or training that could affect the eyes
  • People with physical or mental health conditions that may increase the risks of taking part or affect how well study assessments can be completed (for example, dementia)
  • People who have previously received electrical stimulation treatment to the eye, or taken part in a visual training study, within the past 12 months
  • People with uncontrolled high blood pressure or uncontrolled diabetes
  • People who are pregnant or breastfeeding
  • People with a history of brain surgery (including craniotomy or burr hole surgery), serious head injury, brain tumour, abnormal blood vessels in the brain, or other surgery inside the skull

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886 972653340

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 January 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in visual field mean deviation (MD) from baseline to post-treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov